Menu
ncarol.com
  • Home
  • Business
  • Health
  • Real Estate
  • Non-profit
  • Arts
  • Technology
  • Entertainment
  • Education
ncarol.com

Lineus Medical's CEO Vance Clement joins the 2025 Association of Vascular Access Board of Directors
ncarol.com/10269488

Trending...
  • Suzanne Harp named Managing Director in Texas, USA
  • Anthony B. Bonapart Featured on the Cover of Entrepreneurs in the Spotlight Magazine
  • VoodooSoft Unveils SiriusLLM: The World's First ChatGPT-Like AI Malware Detection Engine
Lineus Medical CEO, Vance Clement AVA Logo Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Vance Clement, CEO of Lineus Medical, has been selected to join the Association of Vascular Access (AVA) Board of Directors as a Director at Large for a two-year term. AVA is an association of healthcare professionals whose mission is to advance the global practice of vascular access, through awareness, advocacy, and education to improve healthcare outcomes. Since 1985, they have worked to improve vascular access care and promote vascular access specialty. During Vance's time on the board, he will highlight the importance of vascular access care, provide support to local vascular access networks (VAN) across the nation, and grow AVA's membership.  When asked about being selected to join the board Vance said, "It is an honor to join the AVA Board of Directors.  I consider AVA to be the preeminent organization for anyone working in the vascular access space.  I look forward to helping AVA grow its membership."

Vance Clement has worked in the medical device industry for over 30 years. He is a frequent speaker at VAN chapter meetings across the country. He has served as the co-founder and CEO of Lineus Medical since 2015 and is passionate about improving IV care and advancing the science around IV care. Under his leadership, Lineus Medical brought the first break away device for medical lines, SafeBreak Vascular, to market.

More on ncarol.com
  • Chappaqua's Annual Townwide Summer Sale – Unbeatable Savings at Your Favorite Local Boutiques!
  • Skyline Partners with ZenSpace to Offer Private Meeting Pods for Trade Show Exhibitors
  • AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
  • Construcción del Corredor Norte–Sur (NSC) de Singapur
  • New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

1.          Data on File

MKG 0287 Rev 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Bang Bang Burgers and Orrman's Cheese Shop Unleash The Mac Daddy for National Mac & Cheese Day
  • Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
  • Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
  • Community-Based Marriage Enrichment Support
  • Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
  • Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
  • $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
  • $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
  • Scott Burton Releases Chaos: The Weight of a Memory, a Poetic Journey Through What Still Lingers
  • The Business Hyve Opens Waitlist for Groundbreaking Community Built for Small Business Success
  • Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
  • Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
  • Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
  • Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
  • AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
  • The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
  • $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
  • Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
  • Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
  • Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
_catLbl0 _catLbl1

Popular on ncarol.com

  • Real Estate CEO Launches Explosive New Book After $275,784 Wire Fraud Incident - 102
  • Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
  • Scott Burton Announces Chaos: Volume 1 – A Journal of Being Human
  • $750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
  • Pregis Empowers Foam-in-Place Customers to Fight Water Insecurity with Inspyre Film
  • Shelter Structures America Appoints Shannon Heller as New Inventory Manager, Bolstering Operational Excellence in the Commercial Tent Industry
  • Fusion Marketing Group Celebrates 15 Years of Transforming Healthcare Recruitment Marketing
  • Western Carolina Emergency Network Accepts 2025 ReadyCommunities Partnership/CCROA National Service Award for Collaboration to Augment Local Response
  • JMC Princess Announces Release of Empowering New Single "PRETTY" – A Summer Anthem for Young Girls Everywhere
  • Kaplan Morrell Applauds Passage of Landmark Workers' Compensation Reform in Colorado

Similar on ncarol.com

  • Digital Watchdog Launches New myDW Cloud Services
  • AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
  • Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
  • Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
  • Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
  • Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
  • Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
  • Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
  • Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
  • Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute